Natco Pharma Q1 Results
- BSE: 524816
- NSE: NATCOPHARM
- ISIN: INE987B01026
- Sector: Biotechnology & Drugs
BSE
1,322
29.70 (2.30%)
29.70 (2.30%)Volume58.85 K
Updated: Mon 28 Oct, 2024 | 15:29:54
NSE
1,323.2531.35 (2.43%)
31.35 (2.43%)Volume4.04 L
Updated: Mon 28 Oct, 2024 | 15:43:39
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
- Total Income₹1,362.60 Cr.(27.55%)
- Operating Profit₹760.70 Cr.(72.18%)
- Profit After Tax₹668.50 Cr.(73.05%)
- Operating Margin55.83%(31.42%)
Note: Comparison is on YoY basis
Quarterly - Natco Pharma Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 24 | Mar 23 | QoQ Comp | Jun 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 1,362.60 | 897.90 | -% | 1,140.50 | -% |
| Selling/ General/ Admin Expenses Total | 142.00 | 118.90 | -% | 138.20 | -% |
| Depreciation/ Amortization | 44.10 | 41.00 | -% | 43.50 | -% |
| Other Operating Expenses Total | 235.60 | 181.50 | -% | 278.30 | -% |
| Total Operating Expense | 601.90 | 599.80 | -% | 656.00 | -% |
| Operating Income | 760.70 | 298.10 | -% | 484.50 | -% |
| Net Income Before Taxes | 803.60 | 324.40 | -% | 500.00 | -% |
| Net Income | 668.50 | 275.80 | -% | 420.30 | -% |
| Diluted Normalized EPS | 37.32 | 15.10 | -% | 23.26 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01Afcons Infrastructure IPO day 2: GMP, subscription status, review, other details. Apply or not?
3 min read28 Oct 2024 - Markets
02Usha Financial Services IPO Day 3: GMP, subscription status & other key details about the SME issue
2 min read28 Oct 2024 - Markets
03Upcoming IPO: NTPC Green Energy gets SEBI nod for ₹10,000 crore IPO
2 min read28 Oct 2024